Last reviewed · How we verify

Other parenteral antifungal drugs

Astellas Pharma Europe B.V. · Phase 2 active Small molecule

Other parenteral antifungal drugs is a Small molecule drug developed by Astellas Pharma Europe B.V.. It is currently in Phase 2 development. Also known as: caspofungin, anidulafungin, fluconazole, itraconazole.

At a glance

Generic nameOther parenteral antifungal drugs
Also known ascaspofungin, anidulafungin, fluconazole, itraconazole, voriconazole
SponsorAstellas Pharma Europe B.V.
ModalitySmall molecule
PhasePhase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Other parenteral antifungal drugs

What is Other parenteral antifungal drugs?

Other parenteral antifungal drugs is a Small molecule drug developed by Astellas Pharma Europe B.V..

Who makes Other parenteral antifungal drugs?

Other parenteral antifungal drugs is developed by Astellas Pharma Europe B.V. (see full Astellas Pharma Europe B.V. pipeline at /company/astellas-pharma-europe-b-v).

Is Other parenteral antifungal drugs also known as anything else?

Other parenteral antifungal drugs is also known as caspofungin, anidulafungin, fluconazole, itraconazole, voriconazole.

What development phase is Other parenteral antifungal drugs in?

Other parenteral antifungal drugs is in Phase 2.

Related